Somatic Epigenetic Silencing of RIPK3 Inactivates Necroptosis and Contributes to Chemoresistance in Malignant Mesothelioma.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Yinfei TanJoseph R Testa

Abstract

Receptor-interacting protein kinase 3 (RIPK3) phosphorylates effector molecule MLKL to trigger necroptosis. Although RIPK3 loss is seen in several human cancers, its role in malignant mesothelioma is unknown. This study aimed to determine whether RIPK3 functions as a potential tumor suppressor to limit development of malignant mesothelioma. RIPK3 expression was examined in 66 malignant mesothelioma tumors and cell lines. Promoter methylation and DNMT1 siRNA studies were performed to assess the mode of RIPK3 silencing in RIPK3-deficient malignant mesothelioma cells. Restoration of RIPK3 expression in RIPK3-negative malignant mesothelioma cells, either by treatment with 5-aza-2'-deoxycytidine or lentiviral expression of cDNA, was performed to assess effects on cell viability, necrosis, and chemosensitization. Loss of RIPK3 expression was observed in 42/66 (63%) primary malignant mesotheliomas and malignant mesothelioma cell lines, and RT-PCR analysis demonstrated that downregulation occurs at the transcriptional level, consistent with epigenetic silencing. RIPK3-negative malignant mesothelioma cells treated with 5-aza-2'-deoxycytidine resulted in reexpression of RIPK3 and chemosensitization. Ectopic expression of RIPK3 also resul...Continue Reading

References

Nov 21, 1995·Proceedings of the National Academy of Sciences of the United States of America·A B BianchiJ R Testa
Nov 5, 1997·Nature Biotechnology·R ZuffereyD Trono
Jun 11, 2004·Annual Review of Biochemistry·Xuejun Jiang, Xiaodong Wang
Jun 9, 2006·Acta Oncologica·Sara L O'KaneLynn Cawkwell
Aug 30, 2011·Nature Genetics·Joseph R TestaMichele Carbone
Jun 8, 2012·Cell Reports·Christopher P DillonDouglas R Green
Dec 25, 2012·Immunity·Tae-Bong KangDavid Wallach
May 13, 2014·Cell·Christopher P DillonDouglas R Green
May 14, 2014·Proceedings of the National Academy of Sciences of the United States of America·William J KaiserEdward S Mocarski
Jun 7, 2014·Cell Death and Differentiation·W D CookD L Vaux
Aug 19, 2014·Nature·Marius DannappelManolis Pasparakis
Jan 17, 2015·Nature·Manolis Pasparakis, Peter Vandenabeele
Feb 7, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Masaki NasuMichele Carbone
Oct 31, 2015·Cell Cycle·Yves DondelingerMathieu J M Bertrand
Dec 19, 2015·Nature Reviews. Cancer·Wynand P RoosBernd Kaina
Apr 7, 2016·Cellular and Molecular Life Sciences : CMLS·Jing ZhangLiming Sun
Dec 27, 2016·Cancer Cell·Anne T SchneiderTom Luedde
Apr 30, 2017·Trends in Cancer·Ayaz NajafovJunying Yuan
May 10, 2017·The Journal of Experimental Medicine·Gui-Wei HeChristoph Becker

❮ Previous
Next ❯

Citations

Oct 17, 2021·Cellular and Molecular Life Sciences : CMLS·Shanhui LiuJiwang Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.